Peptide Antibiotics Market

Peptide Antibiotics Market : Global Industry Analysis 2014 - 2018 and Opportunity Assessment 2019 - 2029

  • Ongoing
  • June 2020
  • REP-GB-10419
  • PDF PPT EXCEL
Peptide Antibiotics Market
  • SELECT LICENSE TYPE :

  • US$5,000
  • US$7,500
  • US$10,000

This Peptide Antibiotics market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Peptide Antibiotics market.


Peptide antibiotics belong to the class of anti-infective and antitumor antibiotic containing polypeptide chains. These peptide antibiotics usually fall into two categories ribosomal synthesized and non-ribosomal synthesized peptide antibiotics. Due to various benefits of peptide antibiotics such as high efficacy, high specificity, low toxicity, etc. the peptide antibiotics are highly in demand. Also, due to rising cases of antibiotic resistance creating a threat for the manufacturer, the peptide antibiotics were taken into account to overcome the above issue. The intensive research and development activities in the field of peptide antibiotics are likely to create more scopes and opportunities for the market players over the forecast period.

Peptide Antibiotics Market: Drivers and Restraints

Increasing demand for peptide antibiotics in hospitals and clinics is the major factor driving the growth of the peptide antibiotics market. The intensive research and development activities in the field of peptide antibiotics are further anticipated to support growth of the peptide antibiotics market. The market players are heavily investing in the research and development activities to expand the applications of peptide antibiotics. Also, the growing competition among the market players and rapid upsurge in the number of manufacturers are further expected to aid in the growth of the peptide antibiotics market. Also, the increasing FDA approval of peptide antibiotics drugs and stringent reimbursement policy is boosting the growth of the peptide antibiotics market. Recent advancement and innovation in the field of peptide antibiotics are creating a favourable scenario for peptide antibiotics market. However, there are many side effects associated with the long term use of the peptide antibiotics, which in turn is hampering the growth of the peptide antibiotics market. 

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Peptide Antibiotics Market: Overview

The peptide antibiotics market is projected to witness prominent growth during the forecast period. On the basis of product type, the peptide antibiotics market is categorized into ribosomal synthesized peptide antibiotics and non-ribosomal synthesized peptide antibiotics. Among the product type, non-ribosomal synthesized peptide antibiotics segment is expected to dominate the peptide antibiotics market, owing to the increasing demand and availability of these peptide antibiotics. Among the route of administration, the oral segment is expected to dominate the peptide antibiotics market. Based on the distribution channel, retail pharmacy is accounted to have a significant market share in the peptide antibiotics market due to higher patient footfall.

Peptide Antibiotics Market: Regional Wise Outlook

The Peptide antibiotics market is anticipated to experience robust growth in the near future. North America is accounted to have a significant market share in terms of revenue and is expected to dominate the peptide antibiotics market over the forecast period. This is attributed to the presence of market players in the region and increasing demand for antibiotics in the region. Also, the increasing R & D activities in the region are further anticipated to surge the peptide antibiotics market growth in the region. Europe is expected to be the second most lucrative region, owing to the higher adoption of peptide antibiotics in the region. Also, improvement in healthcare infrastructure facility and FDA approval of peptide antibiotics is further anticipated to boost the growth of the peptide antibiotics market in the region. The Asia Pacific is projected to witness significant growth over the forecast period. This is due to the rising awareness of people towards their health and increasing disposable income in developing countries like India, China, etc. Latin America is subjected to register stable growth in the peptide antibiotics market.

Peptide Antibiotics Market: Key Players

The Key players operating in peptide antibiotics market are Novartis, Eli Lilly & co., GlaxoSmithKline Plc., Pfizer, Theravance Biopharma, Vicuron Pharmaceuticals, AMP Therapeutics, Savara Pharmaceuticals, Pacgen Life Science Corporation, and Kasten

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology Matrix
  • Value Chain

Regional analysis of the Peptide Antibiotics Market report includes

  • North America
  • Latin America
  • Europe
  • South  Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Peptide Antibiotics Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Peptide Antibiotics Market: Segmentation

The peptide antibiotics market is segmented based on product type, route of administration, and distribution channel.

Based on Product Type, the global Peptide Antibiotics Market is segmented as:

  • Ribosomal Synthesized Peptide Antibiotics
  • Non-ribosomal Synthesized Peptide Antibiotics

Based on the route of administration, the global Peptide Antibiotics Market is segmented as:

  • Oral
  • Intravenous
  • Intramuscular
  • Topical
  • Others

Based on the distribution channel, the global Peptide Antibiotics Market is segmented as:

  • Hospital
  • Retail Pharmacy
  • Drug Stores
  • Others

Peptide Antibiotics Market Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Peptide Antibiotics Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Peptide Antibiotics Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

* indicates mandatory fields
Our Clients

Request Sample Request customization Request Methodology